Septerna, Inc. · Brief

Next report

8 days

Nov 9 · before openest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

1 of 7≥ implied

Nov 20 '24—▼−3.16%—

Mar 27 '25±18.8%▲+2.44%×0.13

May 15 '25±6.6%▼−2.77%×0.42

Aug 11 '25±16.1%▼−2.52%×0.16

Q3 FY25±25.7%▼−2.22%×0.09

Q1 FY26±8.3%▼−3.58%×0.43

May 11 '26±9.9%▲+5.39%×0.54

Q2 FY26±11.9%▲+22.93%×1.93

quarterimplied−30%0+30%realized×

Q2 FY26±11.9%▲+22.93%×1.93

May '26±9.9%▲+5.39%×0.54

Q1 FY26±8.3%▼−3.58%×0.43

Q3 FY25±25.7%▼−2.22%×0.09

Aug '25±16.1%▼−2.52%×0.16

May '25±6.6%▼−2.77%×0.42

2 older reports

Mar '25±18.8%▲+2.44%×0.13

Nov '24—▼−3.16%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 9 report · est.

Bull2 of 3

156managers reporting a position in the latest quarterly filings13F · Jun 30 '26

2 of 21of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

Bear2 of 4

6 of 7recent reports where the move came in under the options implied rangeEarnings history

100.00%of revenue from the largest disclosed customer Vertex Pharmaceuticals IncorporatedSEC filings

AI captions · Sep 28 '26once per report · top 2 per case

SEPN report session

No linked exposure.

Oct 26impliedImplied move: ±14.9% into Nov 9 earnings (Oct 26 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.